-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On September 23, Asia-Pacific Pharmaceuticals issued an announcement stating that it had recently received the "Drug Supplementary Application Approval Notice" for cefmetazole sodium for injection approved and issued by the National Medical Products Administration.
Cefmetazole sodium is highly stable to β-lactamase, and has the same strong antibacterial activity against β-lactamase-producing and non-β-lactamase-producing sensitive bacteria
In addition, cefmetazole sodium also has a strong antibacterial effect on anaerobic bacteria such as Peptostreptococcus, Bacteroides, Prevotella (except Biloba Prevotella) and other anaerobic bacteria